162 related articles for article (PubMed ID: 9869464)
1. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
3. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Abu el-Asrar AM; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L
Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
[TBL] [Abstract][Full Text] [Related]
5. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
Kon CH; Occleston NL; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
[TBL] [Abstract][Full Text] [Related]
7. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
8. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
[TBL] [Abstract][Full Text] [Related]
10. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107
[TBL] [Abstract][Full Text] [Related]
12. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
13. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis].
Bresgen M; Baum U; Esser P; Wiedemann P; Heimann K
Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
Kauffmann DJ; van Meurs JC; Mertens DA; Peperkamp E; Master C; Gerritsen ME
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation in proliferative vitreoretinopathies.
Verdejo C; Marco P; Renau-Piqueras J; Pinazo-Duran MD
Eye (Lond); 1999 Apr; 13 ( Pt 2)():183-8. PubMed ID: 10450379
[TBL] [Abstract][Full Text] [Related]
16. Expression of binding sites for beta chemokines on human astrocytes.
Andjelkovic AV; Kerkovich D; Shanley J; Pulliam L; Pachter JS
Glia; 1999 Dec; 28(3):225-35. PubMed ID: 10559781
[TBL] [Abstract][Full Text] [Related]
17. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.
Hattenbach LO; Allers A; Gümbel HO; Scharrer I; Koch FH
Retina; 1999; 19(5):383-9. PubMed ID: 10546932
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
Kojima S; Yamada T; Tamai M
Jpn J Ophthalmol; 2001; 45(1):40-5. PubMed ID: 11163044
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
Clausen R; Weller M; Hilgers RD; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):283-6. PubMed ID: 2376377
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in proliferative vitreoretinopathy.
Limb GA; Little BC; Meager A; Ogilvie JA; Wolstencroft RA; Franks WA; Chignell AH; Dumonde DC
Eye (Lond); 1991; 5 ( Pt 6)():686-93. PubMed ID: 1800167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]